| scholarly article | Q13442814 |
| P2093 | author name string | Portman RJ | |
| Eddy A | |||
| Hogg RJ | |||
| Ingelfinger J | |||
| Lemley KV | |||
| Milliner D | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nephrotic syndrome | Q504790 |
| P304 | page(s) | 1242-1249 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Pediatrics | Q7159238 |
| P1476 | title | Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and eli | |
| P478 | volume | 105 |
| Q36741100 | Ankle brachial index in children with steroid-resistant nephrotic syndrome |
| Q83034332 | Blood pressure load, proteinuria and renal function in pre-hypertensive children |
| Q34629741 | CKD and hypertension during long-term follow-up in children and adolescents previously treated with extracorporeal membrane oxygenation. |
| Q36476017 | Cerebral sinovenous thrombosis and idiopathic nephrotic syndrome in childhood: report of four new cases and review of the literature |
| Q57297960 | Changes in the Thyroid Hormone Profiles in Children with Nephrotic Syndrome |
| Q87393507 | Chapter 1: Definition and classification of CKD |
| Q47846927 | Circannual variation in the onset and relapse of steroid-sensitive nephrotic syndrome |
| Q36420940 | Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative |
| Q37808375 | Clinical practice: proteinuria |
| Q35862133 | Deflazacort Versus Prednisolone: Randomized Controlled Trial in Treatment of Children With Idiopathic Nephrotic Syndrome |
| Q38677859 | Dengue hemorrhagic fever and the kidney |
| Q34214578 | Diabetic kidney disease in children and adolescents |
| Q97544645 | Diagnostic approach to orthostatic proteinuria: a combination of urine micro-proteinuria with ultrasonography of the left renal vein |
| Q33379536 | Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome |
| Q54334752 | Early renal damage among children living in the region of highest burden of chronic kidney disease of unknown etiology (CKDu) in Sri Lanka. |
| Q58556275 | Effect of angiotensin converting enzyme gene I/D polymorphism in South Indian children with nephrotic syndrome |
| Q33943315 | Enzymatic disease of the podocyte. |
| Q38137984 | Evaluation of renal function after successful treatment for unilateral, non-syndromic Wilms tumor |
| Q84978295 | Evidence-based practice guideline for the treatment of CKD |
| Q33612811 | Evolution of blood pressure in children with congenital and acquired solitary functioning kidney |
| Q83888906 | Expression of P-glycoprotein in lymphocytes of children with nephrotic syndrome treated with glucocorticoids |
| Q36700001 | Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease |
| Q30475964 | Glomerular filtration rate and prevalence of chronic kidney disease in Wilms' tumour survivors. |
| Q44443643 | Growth in steroid-responsive nephrotic syndrome: a study of 85 pediatric patients. |
| Q90028665 | Hematuria and Proteinuria in Children |
| Q37288569 | Hemolytic uremic syndrome: late renal injury and changing incidence-a single centre experience in Canada |
| Q46678926 | High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity |
| Q36111425 | Highlights for the management of a child with proteinuria and hematuria |
| Q57040510 | Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study) |
| Q36322955 | Long-Term Outcomes in Children with Steroid-Resistant Nephrotic Syndrome Treated with Calcineurin Inhibitors |
| Q50793921 | Long-term enzyme replacement therapy for Fabry disease: efficacy and unmet needs in cardiac and renal outcomes. |
| Q33622129 | Long-term prognosis of 4 children with steroid-sensitive nephrotic syndrome and relapse after 30 years of age. |
| Q54320254 | Losartan and enalapril are comparable in reducing proteinuria in children. |
| Q51931021 | MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children. |
| Q38243597 | Management of proteinuria in the transplanted patient |
| Q52945061 | Minimal Change Disease. |
| Q51710218 | Multiple drug-resistant gene 1 in children with steroid-sensitive nephrotic syndrome. |
| Q35691386 | Mycophenolate mofetil (MMF) treatment efficacy in children with primary and secondary glomerulonephritis |
| Q35207868 | Nephrotic syndrome in childhood. |
| Q39680268 | Normal values of urine total protein- and albumin-to-creatinine ratios in term newborns |
| Q44481330 | Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade |
| Q40558040 | Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccine |
| Q36914364 | Orthostatic proteinuria and the spectrum of diurnal variability of urinary protein excretion in healthy children |
| Q43062006 | Pediatric reference intervals for random urine calcium, phosphorus and total protein |
| Q37644838 | Persistent microalbuminuria in human immunodeficiency virus infected children in kano, Nigeria |
| Q59167474 | Predictors of remission and relapse in idiopathic nephrotic syndrome: a prospective cohort study |
| Q58689772 | Predisposing Factors for Deep Venous Thrombosis in Children and Adolescents with Nephrotic Syndrome |
| Q33622118 | Pregnancy in 4 women with childhood-onset steroid-sensitive nephrotic syndrome |
| Q83989287 | Profiling proteinuria in pediatric patients |
| Q91913655 | Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study |
| Q35234337 | Progression of glomerular and tubular disease in pediatrics |
| Q35547794 | Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK) |
| Q38879216 | Proteinuria and progression of pediatric chronic kidney disease: lessons from recent clinical studies |
| Q39719964 | Proteinuria in South Asian children: prevalence and determinants |
| Q33683988 | Randomized, double-blind, controlled study of losartan in children with proteinuria. |
| Q64996598 | Reciprocal Relationship Between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome. |
| Q93609219 | References |
| Q34574488 | Regulatory and effector T cells changes in remission and resistant state of childhood nephrotic syndrome |
| Q51899832 | Reliability of different expert systems for profiling proteinuria in children with kidney diseases. |
| Q52714201 | Renal Complications of Lipodystrophy: a closer look at the natural history of kidney disease. |
| Q34589383 | Renal effects of dental amalgam in children: the New England children's amalgam trial |
| Q51489614 | Renal function and solitary kidney disease: Wilms tumour survivors versus patients with unilateral renal agenesis. |
| Q44050858 | Renal parenchymal thickness in children with solitary functioning kidney |
| Q48799925 | Renin-angiotensin-aldosterone system inhibitors in pediatric focal segmental glomerulosclerosis |
| Q46699224 | Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome |
| Q33762358 | Revised guidelines for management of steroid-sensitive nephrotic syndrome |
| Q36003160 | Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial |
| Q36407310 | Rituximab therapy for juvenile-onset systemic lupus erythematosus |
| Q36022953 | Role of routine urinalysis in asymptomatic pediatric patients |
| Q24650910 | Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease |
| Q36603656 | Screening for urinary biomarkers of steroid-resistant nephrotic syndrome in children |
| Q37065608 | Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report |
| Q64063382 | Simplified Algorithm for Evaluation of Proteinuria in Clinical Practice: How should A Clinician Approach? |
| Q35233125 | Steroid-sensitive nephrotic syndrome in children: triggers of relapse and evolving hypotheses on pathogenesis |
| Q34993566 | TRPC channel modulation in podocytes-inching toward novel treatments for glomerular disease |
| Q44752973 | Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome |
| Q42945765 | Th2 cells predominate in idiopathic steroid-sensitive nephrotic syndrome |
| Q64064022 | The Evaluation of a 19-Year-Old With Hypertension and Proteinuria: A Case Report |
| Q28195778 | The Management of Idiopathic Nephrotic Syndrome in Children |
| Q85023484 | The Teenager With Asymptomatic Proteinuria: Think Orthostatic First |
| Q80809102 | The influence of urinary flow rate in children on excretion of markers used for assessment of renal damage: albumin, gamma-glutamyl transpeptidase, N-acetyl-beta-D -glucosaminidase, and alpha1-microglobulin |
| Q34563968 | The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome |
| Q36510669 | Therapeutic strategies to slow chronic kidney disease progression |
| Q53222519 | Triggers of relapse in steroid-dependent and frequently relapsing nephrotic syndrome. |
| Q35180382 | Urinary indices during relapse of childhood nephrotic syndrome |
| Q33246237 | Urinary proteome of steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome of childhood |
| Q33248438 | Urine proteomic profiling of pediatric nephrotic syndrome |
| Q85158302 | Vertebral fractures despite normal spine bone mineral density in a boy with nephrotic syndrome |
| Q37550915 | Wilms' tumour 1 gene mutations in south Indian children with steroid-resistant nephrotic syndrome |
Search more.